FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.2  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 100mg tablets (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 100mg tablets (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Desogestrel 75microgram tablets 168 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Desogestrel 75microgram tablets 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Desogestrel 75microgram tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Desogestrel 75microgram tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Flecainide 50mg tablets 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Sovereign Medical Ltd) 84 capsule 6 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Sovereign Medical Ltd) 84 capsule 6 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Sovereign Medical Ltd) 56 capsule 4 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Sovereign Medical Ltd) 56 capsule 4 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitisinone 5mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitisinone 5mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitisinone 10mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitisinone 10mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Eplerenone 25mg tablets (Tillomed Laboratories Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Eplerenone 25mg tablets (Tillomed Laboratories Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Eplerenone 50mg tablets (Tillomed Laboratories Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Eplerenone 50mg tablets (Tillomed Laboratories Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 323 of 342 Next End

    This concept is not in any reference sets

    Back to Start